Published February 5, 2008
| Version v1
Patent
Open
Identification of novel factors that block programmed cell death or apoptosis by targeting JNK
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
Methods and compositions for modulating apoptosis by acting on the c-Jun-N-terminal kinase (JNK) pathway and assays for the isolation of agents capable of modulating apoptosis, including modulators of the JNK pathway are disclosed. A method of modulating JNK pathway independent of Gadd46beta is disclosed. Methods and compositions are presented for the preparation and use of novel therapeutic compositions for modulating diseases and conditions associated with elevated or decreased apoptosis.
Files
US7326418.pdf
Files
(4.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:bd5746ff95e48d00fc43ab2852f1f771
|
4.3 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 36504 A
- Patent number
- US 7326418 B2
- Other
- oai:uchicago.tind.io:8791
Dates
- Patent filed
-
2004-11-29